Ki Summary

Reaction Details

Report a problem with these data

Target

GTPase KRas [G12C]

Ligand

BDBM608857

Substrate/Competitor

n/a

Meas. Tech.

Scintillation Proximity Assay (SPA)

IC50

16.0±n/a nM

Citation

Cotesta, S; Gerspacher, M; Leblanc, C; Lorthiois, EL; Liu, B; Machauer, R; Mah, R; Mura, C; Rigollier, P; Schneider, N; Stutz, S; Vaupel, A; Warin, N; Wilcken, R Pyrazolyl derivatives useful as anti-cancer agents US Patent US11702409 Publication Date 7/18/2023

More Info.:

Get all data from this article, Assay Method

GTPase KRas [G12C]

Name:

GTPase KRas [G12C]

Synonyms:

GTPase KRas (G12C) | KRAS | KRAS2 | RASK2 | RASK_HUMAN

Type:

Enzyme Catalytic Domain

Mol. Mass.:

21702.19

Organism:

Homo sapiens (Human)

Description:

P01116[G12C]

Residue:

189

Sequence:

MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM

BDBM608857

n/a

Name

BDBM608857

Synonyms:

US11702409, Example 15a | US11702409, Example 15b

Type

Small organic molecule

Emp. Form.

C32H35ClN8O

Mol. Mass.

583.126

SMILES

CN(C)CCn1ncc2cc(ccc12)-c1nn(C2CC3(C2)CN(C3)C(=O)C=C)c(C)c1-c1c(Cl)c(C)cc2[nH]ncc12 |(6.12,-8.04,;6.89,-6.7,;8.43,-6.7,;6.12,-5.37,;6.89,-4.03,;6.12,-2.7,;6.75,-1.29,;5.6,-.26,;4.27,-1.03,;2.81,-.56,;1.66,-1.59,;1.98,-3.09,;3.45,-3.57,;4.59,-2.54,;.2,-1.11,;-.28,.35,;-1.82,.35,;-2.59,1.69,;-4.08,2.09,;-3.68,3.57,;-2.19,3.17,;-5.17,3.97,;-4.77,5.46,;-3.28,5.06,;-5.86,6.55,;-5.46,8.04,;-7.34,6.15,;-8.43,7.24,;-2.29,-1.11,;-3.76,-1.59,;-1.05,-2.02,;-1.05,-3.56,;-2.38,-4.33,;-3.72,-3.56,;-2.38,-5.87,;-3.72,-6.64,;-1.05,-6.64,;.28,-5.87,;1.75,-6.34,;2.65,-5.1,;1.75,-3.85,;.28,-4.33,)|

Structure